Skip to main content
SpringerLink
Log in

Sulfonylurea-DPP-4 inhibitor combination: risk of hypoglycaemia similar for all combinations

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Dimakos J, et al. Pharmacologic heterogeneity and risk of severe hypoglycemia with concomitant use of sulfonylureas and DPP-4 inhibitors: population-based cohort study. Clinical Pharmacology and Therapeutics : 16 Jun 2023. Available from: URL: http://doi.org/10.1002/cpt.2975

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sulfonylurea-DPP-4 inhibitor combination: risk of hypoglycaemia similar for all combinations. Reactions Weekly 1963, 11 (2023). https://doi.org/10.1007/s40278-023-42067-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-42067-x

Search

Navigation